No Prescription |
 |
 | ||
|
FLEXIDOL Generic Aceclofenac |
|
| ||
No Prescription » Prescription Drugs 7 » FLEXIDOL Generic Aceclofenac Indicated for the relief of pain and inflammation in osteoarthritis rheumatoid arthritis and ankylosing spondylitis. Aceclofenac belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of various chemicals in the body some of which are known as prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause pain swelling and inflammation. Arthritic conditions are one example of this. Aceclofenac is used to relieve pain and inflammation in arthritic conditions. All the medicines in this group reduce inflammation caused by the body's own immune system and are effective pain killers. What is it used for?A form of arthritis (ankylosing spondylitis) Inflammatory disease of the joints Osteoarthritis Buy FLEXIDOL Generic Aceclofenac and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About FLEXIDOL Generic Aceclofenac: Product Type: Prescription Drugs 7 FLEXIDOL ( Generic Aceclofenac ) FLEXIDOL (Generic Aceclofenac) Generic Aceclofenac 100mg 2 x 100 Tablets 4 x 100 Tablets 100 Tablets Generic Aceclofenac FLEXIDOL
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
